Esther Mayowa Pius

Ms. Esther Mayowa Pius

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2026 in Toxics
Verified
Journal Article
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
EPEsther Mayowa Pius
Esther Mayowa Pius
HAHikmah Adeola Abdulganiyu
Hikmah Adeola Abdulganiyu
IAIFEOLUWA OLUWAJENYO ALABI
IFEOLUWA OLUWAJENYO ALABI
VEVictor Oladimeji Eso
Victor Oladimeji Eso
CAChima M. Amadi
Chima M. Amadi
Benign prostatic hyperplasia (BPH) is a significant health issue among ageing men, with ongoing research focused on elucidating its underlying mechanisms and improving experimental models. Testosterone Propionate (TP) is the first line of choice for the induction of BPH in experimental rodent models. However, TP’s controlled status as a Schedule III drug in the United States and a Class C drug in the UK presents challenges in obtaining TP for experimental use, giving preference to the sulpiride model since it is easily obtained as an alternative for the induction and study of BPH. A comprehensive literature search was conducted across multiple electronic databases, including PubMed/MEDLINE, Embase, and Web of Science. The primary PubMed search strategy included combinations of Medical Subject Headings (MeSH) and free-text terms: (“Benign prostatic hyperplasia induction” OR “and rodent models’’) AND (“Testosterone Propionate model”) AND (“sulpiride model”). Studies were included if they induced BPH (using testosterone or sulpiride models). Titles and abstracts were screened for relevance; eligible articles underwent full-text review, with data extracted thematically. No formal risk-of-bias scoring was used due to the narrative approach; instead, studies were appraised by design, rigor, plausibility, and evidence. This study reviewed published and publicly available data, so no ethical approval was required. Although both TP and sulpiride induce BPH via various mechanisms, this review provides a comparative analysis of these two commonly utilised models for studying BPH. In the TP approach, castrated rodents receive daily subcutaneous injections for 4 weeks, resulting in dihydrotestosterone (DHT)-mediated epithelial hyperplasia predominantly affecting the ventral prostate lobes. Conversely, the sulpiride model is non-invasive, employs intact animals treated with sulpiride, and induces hyperprolactinemia-mediated BPH via interactions with androgen and oestrogen receptor pathways that stimulate prostatic stromal and epithelial proliferation, particularly in the lateral and dorsal lobes, representing an alternative method. We also highlight the strengths and limitations of TP and sulpiride in replicating clinical symptoms and examine the toxicological effects of sulpiride on the kidney, testis, liver, and brain. We recommend the sulpiride model for the induction and studying of BPH, as it is readily accessible and closely mimics the pathogenesis of BPH in humans, unlike the TP model, which requires castration.
1

19 April 2024 in Lafia Journal of Scientific and Industrial Research
Verified
Journal Article
Open access
PDF file
EPEsther Mayowa Pius
Esther Mayowa Pius
OAOlubunmi Bolanle Ajayi
Olubunmi Bolanle Ajayi
AMAbubakar Mohammed
Abubakar Mohammed
TATimothy Atinuke
Timothy Atinuke
OOOlofin Opeyemi
Olofin Opeyemi
AMAmina Ladidi Musa
Amina Ladidi Musa
This study assesses the effects of supplemented diet of Discorea dumenturom on antioxidant status of streptozotocin-induced diabetic rats. Twenty-five adult male wistar rats were randomly assigned into five groups each containing five rats, group two to five were subjected to high fat diet for four weeks and was thereafter induced with STZ intraperitoneally (45mg/kg body weight) resulting to type 2 diabetes. The body weight, glucose concentration and the activities the antioxidant enzymes, Glutathione peroxidase (GPx), Glutathione S-transferase (GST), Catalase (CAT), and Malondialdehyde (MDA) and Glutathione concentration in the kidney, heart and liver were assessed. The Post-treatment with 10% and 20% Yellow Bitter Yam significantly reduced glucose and an healthy reduction in weight in treated groups compared to diabetic controls. In diabetic kidneys, GSH and GST were similar to controls, while GPX, CAT, and MDA decreased. Diabetic hearts showed increased CAT, GSH, and MDA, regulated in the treated group. In diabetic livers, GPx, GST, and MDA were consistent across groups, but GSH and CAT significantly (p>0.05) decreased in post-treated groups. The study suggests Dioscorea dumetorum supplementation regulates antioxidant enzymes, indicating potential hypoglycemic and antioxidative effects, particularly in kidney, heart, and liver enzyme activities associated with Type 2 diabetes.

7 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Solomon OwumiSolomon Owumi
Solomon Owumi
EPEsther Mayowa Pius
Esther Mayowa Pius
HAHikmah Adeola Abdulganiyu
Hikmah Adeola Abdulganiyu
IAIFEOLUWA OLUWAJENYO ALABI
IFEOLUWA OLUWAJENYO ALABI
VEVictor Oladimeji Eso
Victor Oladimeji Eso
CAChima M. Amadi
Chima M. Amadi
Background: Benign prostatic hyperplasia (BPH) is a significant health issue among ageing men, with ongoing research focused on elucidating its underlying mechanisms and improving experimental models. Testosterone Propionate (TP) is the first line of choice for the induction of BPH in experimental rodent models. However, TP's controlled status as a Schedule III drug in the United States and a Class C drug in the UK presents challenges in obtaining TP for experimental use, giving preference to the sulpiride model since it is easily obtained as an alternative for the induction and study of BPH. Method: A comprehensive literature search was conducted across multiple electronic databases, including PubMed/MEDLINE, Embase, and Web of Science. The primary PubMed search strategy included combinations of Medical Subject Headings (MeSH) and free-text terms: (“Benign prostatic hyperplasia induction” OR ‘’ and rodent models’’) AND (“Testosterone Propionate model” ) AND (“sulpiride model”). Studies were included if they induced BPH (using testosterone or sulpiride models). Titles and abstracts were screened for relevance; eligible articles underwent full-text review, with data extracted thematically. No formal risk-of-bias scoring was used due to the narrative approach; instead, studies were appraised by design, rigor, plausibility, and evidence. This study reviewed published and publicly available data, so no ethical approval was required. Results: Although both TP and sulpiride induce BPH via various mechanisms, this review provides a comparative analysis of these two commonly utilised models for studying BPH. In the TP approach, castrated rodents receive daily subcutaneous injections for 4 weeks, resulting in dihydrotestosterone (DHT)-mediated epithelial hyperplasia predominantly affecting the ventral prostate lobes. Conversely, the sulpiride model is non-invasive, employs intact animals treated with sulpiride, and induces hyperprolactinemia-mediated BPH via interactions with androgen and oestrogen receptor pathways that stimulate prostatic stromal and epithelial proliferation, particularly in the lateral and dorsal lobes, representing an alternative method. We also highlight the strengths and limitations of TP and sulpiride in replicating clinical symptoms and examine the toxicological effects of sulpiride on the kidney, testis, liver, and brain. Conclusions: we recommend the sulpiride model for the induction and studying of BPH, as it is readily accessible and closely mimics the pathogenesis of BPH in humans, unlike the TP model, which requires castration.